WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹214 Cr | ₹320 Cr | ₹360 Cr | ₹355 Cr | ₹311 Cr |
What is the latest Total Current Liabilities ratio of WANBURY ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹214 Cr |
Mar2023 | ₹320 Cr |
Mar2022 | ₹360 Cr |
Mar2021 | ₹355 Cr |
Mar2020 | ₹311 Cr |
How is Total Current Liabilities of WANBURY Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹214 Cr | -33.10 | |
Mar2023 | ₹320 Cr | -11.05 | |
Mar2022 | ₹360 Cr | 1.24 | |
Mar2021 | ₹355 Cr | 14.25 | |
Mar2020 | ₹311 Cr | - |
Compare Total Current Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹907.9 Cr | -6.4% | -0.5% | 121.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹444,873.0 Cr | -1.9% | 2.7% | 42.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,544.0 Cr | -2.9% | -3.8% | 46.1% | Stock Analytics | |
CIPLA | ₹120,964.0 Cr | -2.2% | 1.4% | 14.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,710.0 Cr | -1.4% | 7.8% | 13.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,744.0 Cr | 2.8% | 0.6% | 35.5% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -6.4% |
-0.5% |
121.5% |
SENSEX | 0.1% |
-4.4% |
8.8% |
You may also like the below Video Courses